Lawrence Steinman, Director at BioAtla, Inc. (BCAB), bought 20,000 shares at $2.05 ($41K) on 2023-12-19, disclosed to the SEC on 2023-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ATNF | BUY | 2023-06-02 | $22K | — | Filing → |
| ATNF | BUY | 2021-12-10 | $21K | — | Filing → |
| BCAB | SELL | 2021-11-03 | $14K | — | Filing → |